COLUMBIA, S.C., Oct. 2, 2024 /PRNewswire/ -- Ambetter from Absolute Total Care, a product offered by a Centene Corporation (NYSE: CNC) company, which provides insurance to under-insured and uninsured populations through the federal Health Insurance Marketplace®, will offer South Carolinians a variety of affordable health insurance plans in plan year 2025. Open enrollment for the Health Insurance Marketplace for South Carolina runs from Nov. 1, 2024, through Jan. 15, 2025. Enroll by Dec. 15 for coverage starting Jan. 1, 2025.
"Ambetter from Absolute Total Care offers a variety of coverage options and health solutions designed to meet each individuals' unique needs," said President and CEO, Absolute Total Care, John McClellan. "Our commitment is not just to provide high quality insurance, but to build a healthier South Carolina for all, where every member feels valued, supported and equipped to thrive."
Ambetter from Absolute Total Care offers quality care, convenient services and valuable rewards that help make health insurance fit within people's lives:
South Carolina residents interested in learning more about Ambetter from Absolute Total Care or enrolling in a health plan during the open enrollment period may visit ambetter.absolutetotalcare.com.
About Ambetter from Absolute Total Care & Ambetter Health
Ambetter from Absolute Total Care serves under-insured and uninsured populations through the federal Health Insurance Marketplace. Ambetter from Absolute Total Care is underwritten by Absolute Total Care, Inc., which is a Qualified Health Plan issuer in South Carolina. Ambetter Health, offering the Ambetter Health Solutions product, is underwritten by Celtic Insurance Company. For more information visit ambetterhealth.com/en/sc. This is a solicitation for insurance. For information on your right to receive an Ambetter from Absolute Total Care plan free of discrimination, or your right to receive language, auditory and/or visual assistance services, please visit ambetterhealth.com/en/ and scroll to the bottom of the page.
Last Trade: | US$60.70 |
Daily Change: | -1.28 -2.07 |
Daily Volume: | 5,650,442 |
Market Cap: | US$30.650B |
February 24, 2025 February 04, 2025 October 30, 2024 |
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load